Pennsylvania HB 475: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

Status: PN 0463 Referred to JUDICIARY (as of 2019-02-12)

State: Pennsylvania · Session: 2019-2020 · Bill: HB 475

Sponsors: Hahn, Barrar, Brown, Dunbar, Gillen, Mackenzie, Masser, Millard, Neilson, Oberlander, Pickett, Readshaw, Ryan, Sappey, Saylor, Topper, Zimmerman

View Pennsylvania HB 475 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.